Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Cash Flow Reinvestment Rate
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Cash Flow Reinvestment Rate of 0.49x as of September 2025, reinvesting CN¥38.83 Million (capex CN¥38.83 Million ) from operating cash flow of CN¥79.81 Million. Check Shandong Jincheng Pharmaceutical and Che cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Cash Flow Reinvestment Rate (2008–2025)
Historical reinvestment intensity for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 18 annual periods. Explore 300233 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Year-by-year capital reinvestment analysis for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. For live market cap and broader valuation context, see Shandong Jincheng Pharmaceutical and Che (300233) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | CN¥102.08 Million | CN¥319.64 Million | CN¥100.88 Million | ▼ -35.3% |
| 2024 | 0.49x | CN¥146.29 Million | CN¥296.59 Million | CN¥142.61 Million | ▼ -5.2% |
| 2023 | 0.52x | CN¥345.61 Million | CN¥664.08 Million | CN¥342.90 Million | ▼ -81.8% |
| 2022 | 2.86x | CN¥731.49 Million | CN¥255.63 Million | CN¥373.67 Million | ▲ +147.6% |
| 2021 | 1.16x | CN¥505.25 Million | CN¥437.19 Million | CN¥376.14 Million | ▲ +44.0% |
| 2020 | 0.80x | CN¥438.44 Million | CN¥546.13 Million | CN¥272.44 Million | ▲ +22.3% |
| 2019 | 0.66x | CN¥379.29 Million | CN¥577.98 Million | CN¥361.65 Million | ▼ -43.2% |
| 2018 | 1.16x | CN¥406.96 Million | CN¥352.20 Million | CN¥349.88 Million | ▼ -11.2% |
| 2017 | 1.30x | CN¥197.63 Million | CN¥151.83 Million | CN¥193.80 Million | ▲ +50.5% |
| 2016 | 0.87x | CN¥208.89 Million | CN¥241.48 Million | CN¥158.89 Million | ▲ +10.8% |
| 2015 | 0.78x | CN¥162.35 Million | CN¥207.92 Million | CN¥159.85 Million | ▲ +7.4% |
| 2014 | 0.73x | CN¥159.57 Million | CN¥219.46 Million | CN¥159.57 Million | ▼ -57.4% |
| 2013 | 1.71x | CN¥160.18 Million | CN¥93.92 Million | CN¥160.18 Million | ▲ +35.2% |
| 2012 | 1.26x | CN¥109.21 Million | CN¥86.61 Million | CN¥109.21 Million | ▼ -41.4% |
| 2011 | 2.15x | CN¥135.00 Million | CN¥62.69 Million | CN¥135.00 Million | ▲ +73.6% |
| 2010 | 1.24x | CN¥134.78 Million | CN¥108.67 Million | CN¥134.78 Million | ▲ +41.5% |
| 2009 | 0.88x | CN¥92.58 Million | CN¥105.62 Million | CN¥92.58 Million | ▼ -49.9% |
| 2008 | 1.75x | CN¥52.87 Million | CN¥30.23 Million | CN¥52.87 Million | — |